A Breathalyzer for Disease
Our Mission: To save 100,000 lives and $1.5B in healthcare costs.
Our Vision: The global leader in Breath Biopsy for early detection and precision medicine.
Breath Biopsy - VOC Biomarkers in Breath
A non-invasive way to access a patient’s metabolome, for early detection and real time monitoring of disease activityLearn about breath biopsy
Our Research Products
Bring VOC biomarker research to your own lab with our complete range of R&D instrumentsOur research products
Our Research Services
VOC biomarker discovery and validation research services with our world class team and facilitiesOur research services
ReCIVA® Breath Sampler
A reliable and reproducible way to capture VOC biomarkers in breath samples
Breath Biopsy Kits
From collection of high quality breath samples, to discovery and validation of VOC biomarkers
Volatile organic compound (VOC) biomarker discovery and targeted analysis for early detection, therapeutic response, drug toxicity and disease monitoring for cancer, inflammatory, and infectious diseases.
Introducing the FAIMS microchip, revolutionary science at the nanoscale
At Owlstone Medical we have developed a chemical sensor on a silicon chip 100x cheaper and 1000x smaller than existing technologies: the FAIMS microchip.
Taking action to permanently change non-invasive medical diagnostics through innovative clinical projects
We have an active clinical diagnostics pipeline across oncology and inflammatory diseases.
Owlstone Medical Announces a Novel Approach to Breath-Based Testing for Investigation of the Onset, Progression, and Treatment of Disease
Owlstone Medical and the International Association of Heat and Frost Insulators and Allied Workers Partner to Identify Breath Biomarkers for the Early Detection of Malignant Mesothelioma
Owlstone Medical Enters into a Strategic Collaboration with Actelion to Develop a Breath-Based Test to Help Facilitate Early Detection of Pulmonary Hypertension
University of Manchester and Owlstone Medical Partner on £250,000 Grant from Asthma UK and Innovate UK for Asthma Diagnostic Development